[HTML][HTML] SUMOylation of Jun fine-tunes the Drosophila gut immune response
A Soory, GS Ratnaparkhi - PLoS Pathogens, 2022 - journals.plos.org
Post-translational modification by the small ubiquitin-like modifier, SUMO can modulate the
activity of its conjugated proteins in a plethora of cellular contexts. The effect of SUMO …
activity of its conjugated proteins in a plethora of cellular contexts. The effect of SUMO …
[HTML][HTML] Portal venous thrombosis associated with use of etonogestrel/ethinyl estradiol vaginal ring
KE Bailey, MJ Tranovich - Clinical Practice and Cases in …, 2020 - ncbi.nlm.nih.gov
Discussion Women using hormonal contraception are approximately four times more likely
to develop thromboembolism. Risk of thromboembolism is similar between users of …
to develop thromboembolism. Risk of thromboembolism is similar between users of …
Management of isolated distal deep venous thrombosis
Venous thromboembolism is the third most common cardiovascular condition, with an
annual incidence estimated at 1 in 1000 persons. 1 Of these, a third present with deep …
annual incidence estimated at 1 in 1000 persons. 1 Of these, a third present with deep …
Continuing to Advance the Venous Agenda: Long‐Term Insights From the CAVA Trial
Recent pharmacologic and technologic advances have transformed the treatment paradigm
for proximal deep vein thrombosis (DVT). 1 The mainstay of therapy involves …
for proximal deep vein thrombosis (DVT). 1 The mainstay of therapy involves …
[PDF][PDF] Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal
KE Bailey, MJ Tranovich - Clinical Practice and Cases in Emergency …, 2020 - core.ac.uk
Discussion: Women using hormonal contraception are approximately four times more likely
to develop thromboembolism. Risk of thromboembolism is similar between users of …
to develop thromboembolism. Risk of thromboembolism is similar between users of …